PANAGORA ASSET MANAGEMENT INC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 883677 Boston, MA

Position in FDMT

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$624,860

+$184,237 QoQ

Shares Held

46,982

-0.7% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 158 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. FDMT ranks #55 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	175,291	$109,300,950
2	INCY	Incyte Corp	881,889	$99,970,937
3	XENE	Xenon Pharmaceuticals Inc.	664,031	$40,080,911
4	MIRM	Mirum Pharmaceuticals, Inc.	337,461	$39,506,559
5	TVTX	Travere Therapeutics, Inc.	490,724	$27,878,030
6	JAZZ	Jazz Pharmaceuticals plc	104,935	$25,286,186
7	RLAY	Relay Therapeutics, Inc.	1,291,182	$24,158,015
8	CLDX	Celldex Therapeutics, Inc.	572,538	$21,304,138

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$624,860	46,982	-0.7%	Shares	Sole	2026-08-06
2026-03-31	$440,623	47,328	+0.7%	Shares	Sole	2026-05-14
2025-12-31	$352,342	46,979	0.0%	Shares	Sole	2026-02-13
2025-09-30	$408,247	46,979	-53.5%	Shares	Sole	2025-11-13
2024-09-30	$1,091,518	100,973	-71.5%	Shares	Sole	2024-11-13
2024-06-30	$7,448,448	354,857	+247.7%	Shares	Sole	2024-07-29
2024-03-31	$3,251,886	102,068	-1.5%	Shares	Sole	2024-05-07
2023-12-31	$2,100,374	103,671	+37.0%	Shares	Sole	2024-02-08
2023-09-30	$963,508	75,688	—	Shares	Sole	2023-10-31
No filing history on record for this holder in this stock.